Vivos Therapeutics Inc

NASDAQ:VVOS   3:59:52 PM EDT
4.62
-0.11 (-2.33%)
Earnings Announcements

Vivos Therapeutics Reports Second Quarter 2021 Financial Results And Operational Update

Published: 08/12/2021 22:11 GMT
Vivos Therapeutics Inc (VVOS) - Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update.
Q2 Revenue Rose 37.5 Percent to $4.5 Million.
Qtrly Net Loss per Share $0.19.
Revenue is expected to be $4.5 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $5.05 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.